Stevanato Group S.p.A (STVN) Depreciation & Amortization (CF) (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Depreciation & Amortization (CF) of $25.0 million for Q1 2026, up 38.97% year-over-year from $18.0 million in Q1 2025, and up 1.7% quarter-over-quarter from $24.6 million in Q4 2025.
Stevanato Group S.p.A (STVN) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $25.0 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $25.0 million, up 38.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.8 million (up 32.59% YoY), and the FY2025 annual result was $87.2 million, up 25.13% from the prior year.
- Depreciation & Amortization (CF) grew to $25.0 million in Q1 2026 per STVN's latest filing, from $24.6 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $25.0 million in Q1 2026 and troughed at $13.1 million in Q3 2022.
- A 5-year average of $17.7 million and a median of $17.1 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) slipped 11.11% in 2024, then soared 45.64% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $13.6 million in 2022, then climbed by 24.85% to $17.0 million in 2023, then dropped by 0.64% to $16.9 million in 2024, then soared by 45.64% to $24.6 million in 2025, then advanced by 1.7% to $25.0 million in 2026.
- Business Quant data shows STVN's Depreciation & Amortization (CF) at $25.0 million in Q1 2026, $24.6 million in Q4 2025, and $21.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 25.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.02 Mn |
| Mar 31, 2026 | 25.02 Mn |
| Dec 31, 2025 | 24.60 Mn |
| Dec 31, 2025 | 24.60 Mn |
| Sep 30, 2025 | 21.37 Mn |
| Sep 30, 2025 | 21.37 Mn |
| Jun 30, 2025 | 20.82 Mn |
| Jun 30, 2025 | 20.82 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Dec 31, 2024 | 16.89 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Sep 30, 2024 | 16.10 Mn |
| Jun 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 18.24 Mn |
| Mar 31, 2024 | 19.35 Mn |
| Mar 31, 2024 | 19.35 Mn |
| Dec 31, 2023 | 17.00 Mn |
| Dec 31, 2023 | 17.00 Mn |